Medscape

Diaphragm Pacing System May Ease Breathing in ALS Patients

April 19, 2005 — Implantation of a minimally invasive diaphragm pacing system (DPS) with therapeutic electrostimulation may help maintain diaphragm function and slow or arrest the rate of respiratory ...
Healio

FDA grants premarket approval to diaphragm pacing system

Please provide your email address to receive an email when new articles are posted on . Synapse Biomedical has received premarket approval from the FDA for its NeuRx Diaphragm Pacing System, which ...
BioWorld

Synapse’s diaphragm pacing system nabs FDA breakthrough status

Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...
Medscape

FDA Grants Humanitarian Use Device Designation for Diaphragm Pacing System in ALS

October 14, 2010 — The US Food and Drug Administration (FDA) has granted humanitarian use device designation for a diaphragm pacing system (NeuRx; Synapse Biomedical, Inc) in patients with amyotrophic ...
BioWorld

Items Tagged with 'Transaeris diaphragm pacing system'

Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...
Crain's Cleveland Business

FDA approval helps broaden access of Synapse Biomedical's diaphragm pacing system

Oberlin-based Synapse Biomedical recently secured U.S. Food and Drug Administration premarket approval for its diaphragm pacing system for use in patients with spinal cord injuries (SCI) who rely on ...
Long Island Press

Commack-based Avery Biomedical Has Sold First Commercial Diaphragm Pacemaker for 50 Years

Avery Biomedical Devices, a manufacturer in Commack, is changing the lives of people around the world with its industry-leading technology: the diaphragm pacemaker. The company’s Avery Breathing ...
FiercePharma

Muscular Dystrophy Association And The ALS Association Fund Clinical Trial Of Diaphragm Pacing System In People With ALS

ALS (also known as Lou Gehrig's disease) attacks the nerve cells that control muscles, ultimately resulting in paralysis of all voluntary muscles, including those used for breathing. Average life ...
WKYC3

FDA approves diaphragm pacing technology tested at University Hospitals to help patients come off ventilators

CLEVELAND — Medical technology that was created in Cleveland has been given emergency approval by the FDA to help patients wean off ventilators. Oberlin-based Synapse Biomedical, working with ...
Business Insider

Synapse Biomedical Receives FDA Emergency Use Authorization for New System to Assist in Weaning Patients off of Ventilators During COVID-19 Pandemic

A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". The word "Markets Insider". Two crossed lines that form an 'X'. It ...
KLFY News 10

Synapse Biomedical Wins New Approval for Diaphragm Pacing System to Free Patients from Ventilators

OBERLIN, Ohio, April 5, 2023 /PRNewswire/ -- Synapse Biomedical, Inc. announced today that the FDA has granted premarket approval (PMA) of the NeuRx ® Diaphragm Pacing System (NeuRx DPS ®) for use in ...